ISN has struggled a bit when getting to the .75+ area and it's...

ISN has struggled a bit when getting to the .75+ area and it's not surprising given the run its had and the profits that are there to be taken at that level. Also marketing is yet to ramp up and proof in the pudding of their business strategy yet to be realised.

A lot of talk here about charts, however i can't help but think that it's only going to take some sort of third party revenue deal or nod on fda approval to see this break the bonds and push beyond the $1 mark. It will happen with this stock, but not sure how it will play out. The US uncertainty has not helped, and probably not surprising given the company's US management and focus that the buying money has stopped coming in for now.

They have a unique product and the market is slowly understanding this. We've come a long way from the plan when new management arrived, i'd be very keen to see them put a cherry on top with some deals that show they are a growing company with strings to their bow and revenue pouring in.

fundamentals will drive isn higher, it's now a matter of how long we have to wait to see the promise realised. DP what did you make of staged sale of 1million at .69 and of this little pause???